Han Kun advises Innovent Biologics, Inc. on its global offering on the Main Board of the Stock Exchange of Hong Kong
October, 2018 - Hong Kong, Mainland China
Han Kun, as the PRC legal counsel to the issuer, has advised Innovent Biologics, Inc. (Stock Code: 1801) on its global offering on the Main Board of the Stock Exchange of Hong Kong.
Innovent Biologics, Inc. aims to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people.
